Iluvien, a sustained release intravitreal implant developed by Alimera Sciences, has been approved in Austria, Portugal and the U.K. for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
Russian Academy of Sciences | National Academy of Sciences | American Academy of Arts and Sciences | Academy of Motion Picture Arts and Sciences | Chinese Academy of Sciences | Bulgarian Academy of Sciences | Polish Academy of Sciences | New York Academy of Sciences | French Academy of Sciences | Academy of Sciences | Sciences Po | Chinese Academy of Social Sciences | Courant Institute of Mathematical Sciences | Computer Sciences Corporation | Nobel Memorial Prize in Economic Sciences | National Academy of Sciences of Ukraine | Faculty of Humanities and Social Sciences, University of Zagreb | Royal Swedish Academy of Sciences | Hungarian Academy of Sciences | Candidate of Sciences | All India Institute of Medical Sciences | Swedish University of Agricultural Sciences | International Institute for Population Sciences | Georgian National Academy of Sciences | Azerbaijan National Academy of Sciences | University of Agricultural Sciences | Prussian Academy of Sciences | National Academy of Television Arts and Sciences | International Union of Biological Sciences | Engineering and Physical Sciences Research Council |